Parkinson's disease
Not yet recruitingStudy of VQ-101 to Slow Progression in Adults with GBA1‑Associated Parkinson’s Disease
- Disease:Parkinson's disease
- Substances:–
Germany- Participants:18–64 years · 65+ years
- Sponsor:Vanqua Bio Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany188 clinical trials in Marburg, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for various cancers, including bladder cancer, diffuse large B-cell lymphoma, and advanced gastro-oesophageal cancer. Studies focus on combination therapies and novel treatment approaches.
Research aims to improve survival rates and treatment effectiveness across multiple cancer types.
Clinical studies investigating treatments for chronic obstructive pulmonary disease, chronic cough, and asthma. Research focuses on innovative therapies for patients with uncontrolled symptoms.
Trials evaluate new medications to improve quality of life for patients with respiratory conditions.
Studies examining treatments for epilepsy and various forms of dementia. Research includes innovative diagnostic approaches and therapeutic interventions.
Focus on improving patient outcomes through advanced treatment methods and early diagnosis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.